Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
NASDAQ:EBIO

Eleven Biotherapeutics (EBIO) Stock Price, News & Analysis

→ 4 Cryptos BETTER than Bitcoin (From True Market Insiders) (Ad)
Free EBIO Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
15.58 million shs
Average Volume
2.86 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
EBIO stock logo

About Eleven Biotherapeutics Stock (NASDAQ:EBIO)

Sesen Bio, Inc. engages in designing, engineering, and developing of targeted protein therapeutics. It offers the Vicinium and Proxinium which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.

EBIO Stock News Headlines

December 2, 2023 | afr.com
7-Eleven Australia’s family owners sell for $1.71b
November 11, 2023 | mirror.co.uk
Eleven councillors quit Labour Party as Keir Starmer refuses to back Gaza ceasefire
August 16, 2023 | foxnews.com
California mayor criticizes Prop 47 after 7-Eleven Sikh employees beat alleged thief
July 31, 2023 | usatoday.com
Free Slurpees? Yes, here's how to get one today and Tuesday, 7-Eleven's 96th birthday
April 9, 2023 | cbsnews.com
Chicago police close in on 7-Eleven robbery suspects in Lawndale
January 27, 2023 | dallasnews.com
A downtown Dallas 7-Eleven that averaged one police call a day has closed
January 26, 2023 | nypost.com
Chef Daniel Humm’s all-vegan menu at Eleven Madison Park blossoms after rough patch
January 15, 2023 | abcnews.go.com
7-Eleven adds new bright purple, zero-sugar Slurpee flavor to the mix
January 15, 2023 | foxnews.com
Eleven New Jersey police officers treated for fentanyl exposure during search, 5 suspects arrested
October 14, 2022 | finance.yahoo.com
7-Eleven, Inc. Introduces Limited Time Only Green Apple Flavor to Slurpee Lineup
September 27, 2022 | finance.yahoo.com
Aeglea BioTherapeutics, Inc. (AGLE)
See More Headlines

Company Calendar

Last Earnings
5/15/2018
Today
5/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EBIO
CUSIP
N/A
CIK
1485003
Web
www.elevenbio.com
Phone
(617) 444-8550
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Optionable
Beta
N/A

Key Executives

  • Thomas R. Cannell
    President, Chief Executive Officer & Director
  • Monica Forbes
    Chief Financial Officer & Treasurer
  • Jeannick Cizeau
    Head of Research
  • Glen C. MacDonald
    Chief Technology Officer
  • Kirstin N. Anderson
    Senior Director-Finance

Key Competitors

View All Competitors

EBIO Stock Analysis - Frequently Asked Questions

How were Eleven Biotherapeutics' earnings last quarter?

Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) issued its quarterly earnings data on Tuesday, May, 15th. The biopharmaceutical company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.14) by $0.03.

What other stocks do shareholders of Eleven Biotherapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eleven Biotherapeutics investors own include Synergy Pharmaceuticals (SGYP), Exelixis (EXEL), Immunomedics (IMMU), Dynavax Technologies (DVAX), Sesen Bio (SESN), iShares Preferred and Income Securities ETF (PFF) and Inovio Pharmaceuticals (INO).

This page (NASDAQ:EBIO) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Next President (Not Trump. Not Biden.)
The Freeport Society
Urgent Nvidia Warning
Altimetry
Elon’s New Device is About to Shock the World
InvestorPlace
"The Biggest Drug Ever" Is Coming
Behind the Markets
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders